Daiichi Sankyo (India)
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent. Daiichi Sankyo, Inc. began operating in the U.S. in 2006. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Daiichi Sankyo (India), India, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
64%
Total
Publications
411
Total Open
Publications
265
Total
Citations
5.8K
Open Access
Percentage
64%
Total
Publications
411
Total Open
Publications
265
Total
Citations
5.8K
Breakdown
Publisher Open
48%
Both
13%
Other Platform Open
4%
Closed
35%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 16%
41
Hybrid 21%
53
No Guarantees 63%
160
Other Platform Open
Domain 54%
38
Institution 47%
33
Preprint 11%
8
Other Internet 11%
8
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 38 |
doaj.org OAI-PMH Repository | Institution | 19 |
National Institute of Informatics | Institution | 9 |
DOI | Other Internet | 6 |
bioRxiv | Preprint | 5 |
Unknown Repository | Other Internet | 3 |
University of Ferrara | Institution | 2 |
Research Square | Preprint | 2 |
University of Modena and Reggio Emilia | Institution | 1 |
University of Milan | Institution | 1 |